4//SEC Filing
PIERCE GLENN 4
Accession 0001104659-22-005021
CIK 0001640266other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:05 PM ET
Size
17.3 KB
Accession
0001104659-22-005021
Insider Transaction Report
Form 4
PIERCE GLENN
Director
Transactions
- Award
Common Stock
2022-01-13+26,300→ 26,300 total - Award
Stock Option (Right to Buy)
2022-01-13+50,000→ 50,000 totalExercise: $2.85Exp: 2032-01-13→ Common Stock (50,000 underlying)
Holdings
- 5,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Consists of shares of common stock issuable under an aggregate of 26,300 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, January 13, 2022. 100% of the shares of common stock underlying the RSU award vest on the six-month anniversary of such vesting commencement date, subject to the Reporting Person's continued service as a director, officer, or otherwise.
- [F2]The securities are directly held by the Pierce Family Trust, dated October 13, 1993 (the "Pierce Family Trust"). The Reporting Person's immediate family members are beneficiaries of the Pierce Family Trust. The Reporting Person expressly disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein.
- [F3]This stock option was issued pursuant to the Plan. 1/5th of the shares of common stock underlying the option vest on each of February 12, 2022, March 12, 2022, April 12, 2022, May 12, 2022 and June 2, 2022, subject to the Reporting Person's continued service as an interim executive officer.
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001256964
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 8:05 PM ET
- Size
- 17.3 KB